Business Segments · D&A
CAG — D&A
Idexx Laboratories CAG — D&A remained flat by 0.0% to $32.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $29.07M to $32.59M. Over 4 years (FY 2021 to FY 2025), CAG — D&A shows an upward trend with a 8.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2025
Rolls up toD&A
How to read this metric
Increasing levels often correlate with a larger installed base of diagnostic equipment or significant recent capital expenditures.
Detailed definition
This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within t...
Peer comparison
Standard operating expense metric for capital-intensive businesses that lease equipment to end-users.
Metric ID:
idxx_segment_cag_depreciation_and_amortizationHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $94.20M | $101.25M | $103.55M | $116.28M | $130.35M |
| YoY Change | — | +7.5% | +2.3% | +12.3% | +12.1% |
Range$94.20M – $130.35M
CAGR+8.5%
Avg YoY Growth+8.5%
Median YoY Growth+9.8%
Current Streak4+ years growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's cag — d&a?
- Idexx Laboratories (IDXX) reported cag — d&a of $32.59M in Q4 2025.
- How has Idexx Laboratories's cag — d&a changed year-over-year?
- Idexx Laboratories's cag — d&a increased by 12.1% year-over-year, from $29.07M to $32.59M.
- What is the long-term trend for Idexx Laboratories's cag — d&a?
- Over 4 years (2021 to 2025), Idexx Laboratories's cag — d&a has grown at a 8.5% compound annual growth rate (CAGR), from $94.20M to $130.35M.
- What does cag — d&a mean?
- The non-cash expense representing the wear and tear or expiration of assets used in the Companion Animal Group segment.